Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Francoise Berlioz-Seux"'
Autor:
Brinley Furey, Francoise Berlioz-Seux, Irina Nikolaevna Kadiyala, Rebecca S. Shawgo, Rima Patel, Patricia Hurter, Michael Briggs, Diane M. Boucher, Howard Li, Karem Reda, Kirk Tanner
Publikováno v:
Journal of Pharmaceutical Sciences. 107:856-862
The reported proof of principle study demonstrated the feasibility of local delivery of a c-Met inhibitor (VXc-140) in a subcutaneous xenograft tumor model. VXc-140 was formulated in a wafer delivery system for direct implantation into the tumor. Sys
Autor:
Hamilton B. Bennett, Paul S. Charifson, Michael P. Clark, Rene Rijnbrand, Colleen F. McNeil, Joshua R. Leeman, Alice W. Tsai, Cassey Huang, Randal Byrn, Nti-Addae Kwame Wiredu, Jones Steven, Francoise Berlioz-Seux, Ursula A. Germann
Publikováno v:
Antimicrobial Agents and Chemotherapy. 59:6007-6016
Through antigenic drift and shifts, influenza virus infections continue to be an annual cause of morbidity in healthy populations and of death among elderly and at-risk patients. The emergence of highly pathogenic avian influenza viruses such as H5N1
Autor:
Simon Giroux, Nigel Ewing, Youssef L. Bennani, Francoise Berlioz-Seux, Rebecca S. Shawgo, Anne-Laure Grillot, Nathalie Chauret, Kevin M. Cottrell, Laval C. Chan, Evelyne Dietrich, Francois Denis, Morris Mark A, John Maxwell, Sanjoy Kumar Das, Lucille L’Heureux, Darius Bilimoria, T. Jagadeeswar Reddy, Subajini Selliah, Caroline Cadilhac, Olivier Nicolas, Jinwang Xu, James A. Henderson, Nagraj Mani
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 25:936-939
The discovery of C2-symmetric bis-thienoimidazoles HCV NS5A inhibitors is herein reported. Two straightforward approaches to access the requisite diyne and biphenyl linker moieties are described. This study revealed the paramount importance of the ar
Autor:
Jian Wang, Anne-Laure Grillot, Carl Poisson, Simon Giroux, Nigel Ewing, Youssef L. Bennani, Rebecca S. Shawgo, Ronald Grey, Louis Vaillancourt, Nathalie Chauret, Darius Bilimoria, Olivier Nicolas, Lucille L’Heureux, Subajini Selliah, Kevin M. Cottrell, B. Govinda Rao, Constantin Yannopoulos, Guy Falardeau, Monica Bubenik, Laval C. Chan, James A. Henderson, Sanjoy Kumar Das, Francois Denis, T. Jagadeeswar Reddy, Caroline Cadilhac, Morris Mark A, Oswy Z. Pereira, Evelyne Dietrich, Nagraj Mani, John Maxwell, Francoise Berlioz-Seux, Bingcan Liu
Publikováno v:
Bioorganicmedicinal chemistry letters. 25(4)
The treatment of HCV with highly efficacious, well-tolerated, interferon-free regimens is a compelling clinical goal. Trials employing combinations of direct-acting antivirals that include NS5A inhibitors have shown significant promise in meeting thi
Autor:
Anne-Laure Grillot, Nigel Ewing, Youssef L. Bennani, Simon Giroux, Nathalie Chauret, Caroline Cadilhac, Kevin M. Cottrell, Olivier Nicolas, T. Jagadeeswar Reddy, Evelyne Dietrich, Lucille L’Heureux, Francois Denis, Oswy Z. Pereira, Rebecca S. Shawgo, Jinwang Xu, Nagraj Mani, Francoise Berlioz-Seux, Jian Wang, Sanjoy Kumar Das, John Maxwell, Bingcan Liu, James A. Henderson, Louis Vaillancourt, Subajini Selliah, Guy Falardeau, Laval C. Chan, Morris Mark A, Carl Poisson, Darius Bilimoria, Monica Bubenik
Publikováno v:
Bioorganicmedicinal chemistry letters. 25(4)
Inhibitors of the HCV NS5A nonstructural protein are showing promising clinical potential in the treatment of hepatitis C when used in combination with other direct-acting antiviral agents. Current NS5A clinical candidates such as daclatasvir, ledipa
Autor:
John Maxwell, Francois Denis, Kevin M. Cottrell, Francoise Berlioz-Seux, Subajini Selliah, Rebecca S. Shawgo, Nigel Ewing, Youssef L. Bennani, Morris Mark A, Anne-Laure Grillot, Laval C. Chan, Simon Giroux, Darius Bilimoria, Nagraj Mani, Caroline Cadilhac, T. Jagadeeswar Reddy, James A. Henderson, Olivier Nicolas, Sanjoy Kumar Das, Nathalie Chauret, Jinwang Xu, Lucille L’Heureux, Evelyne Dietrich
Publikováno v:
Bioorganicmedicinal chemistry letters. 25(4)
The discovery of non-symmetric thienoimidazole-containing HCV NS5A inhibitors is described. The inhibitors herein reported display high potencies against both genotype 1a and 1b. In this follow-up manuscript, we discuss the importance of the linker a
Autor:
Nathalie Chauret, Francoise Berlioz-Seux, Anne-Laure Grillot, Nigel Ewing, Sanjoy Kumar Das, Jinwang Xu, Oliver Nicolas, James A. Henderson, Youssef L. Bennani, Darius Bilimoria, Simon Giroux, Francois Denis, John Maxwell, Caroline Cadilhac, Morris Mark A, Mark N. Namchuk, Nagraj Mani, Laval C. Chan, Lucille L’Heureux, Subajini Selliah, T. Jagadeeswar Reddy, Rebecca S. Shawgo, Kevin M. Cottrell
The discovery of potent thienoimidazole-based HCV NS5A inhibitors is herein reported. A novel method to access the thienoimidazole [5,5]-bicyclic system is disclosed. This method gave access to a common key intermediate (6) that was engaged in Suzuki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6659bdfa639f80381f726c3da883bd65
https://europepmc.org/articles/PMC4027595/
https://europepmc.org/articles/PMC4027595/
Autor:
Donald Hodges, Joseph Prezioso, Ursula A. Germann, Kirk Tanner, Hong Gao, Doris Damian, Francoise Berlioz-Seux, Malar Pannirselvam
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 68:e45-e46